Richard Cawston
About Richard Cawston
Richard Cawston, 51, is GXO’s Chief Revenue Officer and President of Europe (since December 2023). He previously served as President of Europe at GXO from August 2021, and before that was President of XPO Logistics Europe – Supply Chain after joining XPO in 2015 via the Norbert Dentressangle acquisition, where he was Managing Director of the logistics division in the UK and Ireland . Company performance under the NEO team in 2024 included revenue of $11.7B, adjusted EBITDA of $815M, and free cash flow of $251M . The 2022 PSU cycle certified in March 2025 paid 94.5% aggregate, with rTSR at the 14th percentile (0% payout), cumulative organic revenue growth at 20.2% (86.4%), and adjusted EBITDA-to-FCF conversion at 41.3% (200%) . Say-on-pay support was 90% in 2024, signaling strong shareholder alignment with the program design .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| GXO Logistics | President of Europe | Since Aug 2021 | Led European operations at scale; progressed to CRO while retaining Europe remit |
| XPO Logistics Europe | President – Supply Chain | Since Sep 2017 | Directed European supply chain platform integration and growth |
| Norbert Dentressangle | Managing Director, Logistics UK & Ireland | Pre-2015 (joined XPO via the acquisition) | Ran UK/IE logistics operations, later integrated into XPO |
Fixed Compensation
| Component | 2024 Amount | Notes |
|---|---|---|
| Base Salary | $565,000 | Increased from $547,264 set in Dec 2023 |
| Target STI (as % of salary) | 110% | Target dollar $621,500 |
| Actual STI Paid | $0 | NEOs mutually agreed to zero payout for 2024 despite 72.59% funding |
| Stock Awards (Grant-Date Value) | $1,985,080 | PSUs and RSUs granted in 2024 |
| All Other Compensation (2024) | $71,276 | Includes pension-related $58,046 and car allowance $13,230 |
Performance Compensation
2024 Annual STI Scorecard and Outcome
| Metric | Weighting | Target | Achievement | Implied Funding | Committee Outcome |
|---|---|---|---|---|---|
| Adjusted EBITDA | 50% | $775M | 94% | Contributed to 72.59% aggregate | All NEO payouts reduced to $0 |
| Free Cash Flow | 20% | $271M | 92% | Contributed to 72.59% aggregate | All NEO payouts reduced to $0 |
| Organic Revenue | 15% | $10,074M | 99% | Contributed to 72.59% aggregate | All NEO payouts reduced to $0 |
| Net New Business | 15% | 8% | 64% | Contributed to 72.59% aggregate | All NEO payouts reduced to $0 |
Committee added Net New Business to emphasize future profitability and excluded Wincanton impacts from 2024 STI definitions .
2024 Long-Term Incentives (LTI) – Award Structure and Grants
| Element | Design | Cawston 2024 Grant |
|---|---|---|
| PSUs (Core) | 3-year performance (ends 12/31/2026); 34% rTSR vs S&P Midcap 400, 33% 3-yr cumulative organic revenue growth, 33% 3-yr average adjusted EBITDA-to-FCF; Operating ROIC modifier ±10%; payout 0–200%; 1-year post-vest lock-up | 15,049 PSUs |
| RSUs | Time-based vesting in equal installments on 1st/2nd/3rd anniversaries of grant date | 15,049 RSUs |
| Special PSUs (Regional Leaders) | 50% 3-yr Accumulated Net New Business; 50% 3-yr Accumulated Adjusted EBITA; payout 0–200%; performance period ends 12/31/2026 | 10,033 PSUs |
Prior Cycle – 2022 PSUs (Performance Certified in Mar 2025)
| Metric | Threshold (50%) | Target (100%) | Max (200%) | Actual | Payout |
|---|---|---|---|---|---|
| rTSR vs S&P Midcap 400 | 25th pct | 50th pct | 75th pct | 14th pct | 0.0% |
| Cumulative Organic Revenue Growth | 10% | 24% | 40% | 20.2% | 86.4% |
| Avg Annual Adj EBITDA-to-FCF Conversion | 20% | 30% | 40% | 41.3% | 200.0% |
| Weighted Aggregate Payout | — | — | — | — | 94.5% |
Equity Ownership & Alignment
Beneficial Ownership and Outstanding Equity (as of Record Date / 12/31/2024)
| Item | Value | Notes |
|---|---|---|
| Beneficial Ownership (Shares) | 140,238 | Includes 74,215 vested options |
| Ownership % of Outstanding | <1% | Shares outstanding 117,063,470 |
| RSUs Not Vested (# / $) | 38,653 / $1,681,406 (at $43.50) | Company year-end price reference used for valuation |
| Unearned PSUs (# / $) | 46,016 / $2,001,696 (at $43.50) | Target-level reflection per table |
| Stock Options – Exercisable | 74,216 @ $64.91, exp. 6/7/2031 | Vesting history detailed; future tranches at 4th/5th anniversaries |
| Stock Options – Unexercisable | 90,707 @ $64.91, exp. 6/7/2031 | Subject to continued employment |
| Option Exercise Lock-Up | 12-month post-vest sale/transfer lock-up | Applies to shares issued upon option exercise |
| Ownership Guidelines | NEOs: 3x base salary; retain 70% net shares until met | All NEOs in compliance as of Record Date |
| Hedging/Pledging Policy | No pledging/margin accounts or hedging without preclearance | Insider trading policy with blackout windows and preclearance |
Upcoming Vesting Schedules (Selected Grants)
| Grant | Quantity | Vesting Dates |
|---|---|---|
| RSU (Mar 2021) | 2,335 | 3/10/2025 |
| RSU (Mar 2022) | 3,375 | 4/1/2025 and 4/1/2026 |
| RSU (Mar 2023) | 6,729 | 3/7/2025, 3/7/2026, 3/7/2027 |
| RSU (Mar 2024) | 15,049 | 3/7/2025, 3/7/2026, 3/7/2027 |
| PSU (Mar 2022) | 11,165 (earned quantity) | Vests 1/15/2026 |
| PSU (Mar 2024 – Core) | 15,049 (target) | Performance period ends 12/31/2026 |
| PSU (Mar 2024 – Special) | 10,033 (target) | Performance period ends 12/31/2026 |
Employment Terms
Contract and Role Basis
- Role: Chief Revenue Officer & President of Europe (new CRO role assumed Dec 2023) .
- Original offer/service agreements: President–Europe, base not less than £310,000, target bonus 100%, 2021 equity target $600,000; XPO options 75,000 subject to spin-off and vesting terms .
- Equity awards as CRO: 50% RSUs / 50% PSUs; 2024 total equity target $1,500,000 .
Severance and Change-of-Control Economics (as-if on 12/31/2024)
| Scenario | Cash Severance | Equity Acceleration | Benefits Continuation | Total |
|---|---|---|---|---|
| Termination without Cause | $1,186,500 | $1,762,098 | $1,770 | $2,950,368 |
| Voluntary Termination | $565,000 | $0 | $0 | $565,000 |
| Termination for Cause | $0 | $0 | $0 | $0 |
| Disability | $0 | $1,651,869 | $0 | $1,651,869 |
| Death | $0 | $3,683,102 | $0 | $3,683,102 |
| Change-of-Control + Termination (Good Reason/No Cause) | $2,994,500 | $3,683,102 | $1,770 | $6,679,372 |
- Awards accelerate on change-of-control only if not assumed/substituted, or upon involuntary termination/Good Reason (“double trigger”) .
- Clawbacks: Misconduct, restrictive covenant breaches, cause; Dodd-Frank/NYSE-compliant mandatory recovery for restatements (3 fiscal years lookback) .
- Restrictive covenants: Comprehensive non-competition and related covenants for NEOs .
- Insider trading: Blackout periods, preclearance, and prohibitions on hedging and pledging without preclearance .
Compensation Structure Analysis
- Increased emphasis on variable pay: Cawston’s 2024 equity mix is 50% PSUs / 50% RSUs, aligning pay with long-term goals and retention . The company’s program emphasizes variable compensation and performance-based awards .
- STI discipline: Despite a 72.59% funded outcome for 2024, NEOs agreed to $0 payouts, a strong shareholder-friendly signal prioritizing “quality earnings” .
- Performance metric changes: Addition of Net New Business to STI and Operating ROIC modifier to PSUs increases focus on profitable growth and capital efficiency .
- Governance safeguards: No option repricing/discounted exercise prices; stock ownership guidelines and retention; clawbacks; no golden parachute excise tax gross-ups .
Equity Ownership & Alignment Signals
- Skin-in-the-game: 140,238 shares beneficially owned (<1% of outstanding), including 74,216 vested options; meaningful unvested RSUs/PSUs provide continued alignment and retention .
- Options economics: Option exercise price $64.91 vs the $43.50 year-end valuation reference used in tables indicates limited intrinsic value as of 12/31/2024; options expire 6/7/2031 with 12-month post-vest lock-ups .
- Ownership policy compliance: NEOs must hold 3x salary and retain 70% of net shares until met; all NEOs were compliant as of the Record Date .
Performance & Track Record
- 2024 enterprise performance milestones: $11.7B revenue; adjusted EBITDA $815M; $251M free cash flow .
- 2022 PSU outcomes: rTSR underperformed index (0% payout), but strong cash conversion (200%) and solid organic growth (86.4%) yielded 94.5% aggregate payout, evidencing operational execution amid market-relative TSR headwinds .
- Strategy updates: Sales pipeline >$2B (up 15% YoY) and expansion into UK/Germany and new verticals via M&A (Wincanton plc) underline growth execution underpinning revenue/EBITDA metrics .
Say-on-Pay & Shareholder Feedback
- 2024 advisory say-on-pay approval of 90% supports the Committee’s pay-for-performance design and recent metric refinements .
Investment Implications
- Pay-for-performance discipline: Zero 2024 STI payout despite funded score should be viewed as bullish governance for long-term value orientation and may reduce near-term “bonus-driven” turnover risk .
- Vesting calendar: Multiple RSU tranches in March/April 2025–2027 and 2022 PSUs vesting in January 2026 create potential selling windows; note 12-month lock-up constraints on options .
- Alignment and retention: Special PSUs tied to regional Accumulated Net New Business and Adjusted EBITA reinforce direct accountability for value creation in Cawston’s remit .
- TSR sensitivity: Prior-cycle rTSR underperformance (0% payout) highlights external market-relative pressure; stronger cash conversion and organic growth metrics partially mitigate execution risk .
- Governance risk mitigants: Ownership guidelines, clawbacks, non-compete covenants, and hedging/pledging prohibitions lower misalignment risks .
Overall, Cawston’s package is heavily tied to multi-year operational and growth outcomes with strict governance overlays; upcoming vesting schedules and metric designs suggest sustained alignment but also episodic liquidity considerations around vest dates .